Clinical Characteristics, Outcomes in Patients With COVID-19, Multiple Sclerosis

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JUNE 26, 2020

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2020.2581?guestAccessKey=a1a40b9a-1cd9-4667-9f7c-3cbdeed33ef7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062620

 

What The Study Did: The clinical characteristics and outcomes in patients with multiple sclerosis who contract COVID-19 are described in this observational study, which identifies factors associated with COVID-19 severity.

Authors: Celine Louapre, M.D., of the Sorbonne Universite in Paris, is the corresponding author.

 

(doi:10.1001/jamaneurol.2020.2581)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.